Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-31

Clinical Trial Update: Methylphenidate for Treating Children With ADHD and Tourette Syndrome [NA]

View source ↗

Summary

A completed clinical trial evaluated the use of methylphenidate for treating children with attention-deficit/hyperactivity disorder and Tourette syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: Stony Brook University | Conditions: Attention Deficit Disorder With Hyperactivity, Tourette Syndrome | NA | Status: COMPLETED